Cart
sales@molnova.com
IUN76750
CAS No. 1690176-75-0
IUN76750( PAR-2-IN-1 )
Catalog No. M23759 CAS No. 1690176-75-0
IUN76750 is a PAR-?2 signaling pathway inhibitor?with anti-inflammatory and anticancer effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 125 | In Stock |
|
| 25MG | 259 | In Stock |
|
| 50MG | 403 | In Stock |
|
| 100MG | 592 | In Stock |
|
| 500MG | 1242 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIUN76750
-
NoteResearch use only, not for human use.
-
Brief DescriptionIUN76750 is a PAR-?2 signaling pathway inhibitor?with anti-inflammatory and anticancer effects.
-
DescriptionIUN76750 is a PAR-?2 signaling pathway inhibitor?with anti-inflammatory and anticancer effects.
-
In Vitro——
-
In Vivo——
-
SynonymsPAR-2-IN-1
-
PathwayGPCR/G Protein
-
TargetPAR
-
RecptorPAR-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1690176-75-0
-
Formula Weight267.71
-
Molecular FormulaC12H14ClN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:83.33 mg/mL?(311.27 mM;?Need ultrasonic)
-
SMILESCC(C)(C)C1=CC(=NN2C1=NC(=C2)C(=O)OC)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Luc J. Farmer, et al. Imidazopyridazines useful as inhibitors of the par-2 signaling pathway. WO2015048245A1.
molnova catalog
related products
-
Protease-Activated R...
Protease-Activated Receptor-4 diTFA2454 is the proteinase-activated receptor-4 (PAR4)agonist.
-
Protease-Activated R...
Protease-Activated Receptor-4 is the proteinase-activated receptor-4 (PAR4) ?agonist.
-
Parstatin (human)
Cell-permeable peptide cleaved from protease-activated receptor 1 (PAR1) upon receptor activation. Attenuates endothelial cell migration and proliferation (IC50 ~ 3 μM), and induces cell cycle arrest. Promotes activation of caspase-3 and exhibits pro-apoptotic activity in vitro. Inhibits angiogenesis and exhibits cardioprotective activity in vivo.
